FindTrial
Sign In

Efficacy and safety of NexStat topical hemostat powder after endoscopic sinus surgery, a prospective randomized controlled clinical trial

Efficacy and safety of NexStat topical hemostat powder after endoscopic sinus surgery, a prospective randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014401
Enrollment
Unknown
Registered
2018-01-10
Start date
2018-01-22
Completion date
Unknown
Last updated
2018-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhinosinusitis

Interventions

experimental group:hemostatic material
control group:NasoPore packing

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 to 70 years; 2. Subjects with chronic rhinosinusitis patients, symmetry on each side; 3. patients with good compliance; 4. without any contraindication of surgical operation.

Exclusion criteria

Exclusion criteria: 1. a known allergic reaction to the potato; 2. join in other drugs or medical devices clinial trials in recent 4 weeks; 3. uncontrolled systemic disease; 4. women are pregnant or breast-feeding; 5. fungal sinusitis, allergic fungal sinusitis, associated with asthma, nasal sinus tumor; 6. ongoing systemic steroid hormone therapy; 7. cystic fibrosis,primary ciliary dysfunction or Kartagener syndrome etc; 8. Use long-term of anticoagulant or coagulant dysfunction diseases.

Design outcomes

Primary

MeasureTime frame
VAS score;SNOT-22 score;Lund-kennedy score;P.J wormald scores;—

Countries

China

Contacts

Public ContactZhou Bing

Beijing Tongren Hospital, Capital Medical University

entzhou@263.net+86 010 58269207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026